Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Michael Yaron to Arthritis, Rheumatoid

This is a "connection" page, showing publications Michael Yaron has written about Arthritis, Rheumatoid.

 
Connection Strength
 
 
 
1.577
 
  1. Tishler M, Nyman J, Wahren M, Yaron M. Anti-Ro (SSA) antibodies in rheumatoid arthritis patients with gold-induced side effects. Rheumatol Int. 1997; 17(4):133-5.
    View in: PubMed
    Score: 0.069
  2. Elkayam O, Yaron M. Brown-Sequard syndrome as a presenting symptom of cervical myelopathy in a rheumatoid arthritis patient. Clin Exp Rheumatol. 1995 Sep-Oct; 13(5):673-4.
    View in: PubMed
    Score: 0.063
  3. Tishler M, Golbrut B, Shoenfeld Y, Yaron M. Anti-Ro(SSA) antibodies in patients with rheumatoid arthritis--a possible marker for gold induced side effects. J Rheumatol. 1994 Jun; 21(6):1040-2.
    View in: PubMed
    Score: 0.058
  4. Tishler M, Caspi D, Yaron M. Long-term experience with low dose methotrexate in rheumatoid arthritis. Rheumatol Int. 1993; 13(3):103-6.
    View in: PubMed
    Score: 0.052
  5. Tishler M, Caspi D, Yaron M. Methotrexate treatment of rheumatoid arthritis: is a fortnightly maintenance schedule enough? Ann Rheum Dis. 1992 Dec; 51(12):1330-1.
    View in: PubMed
    Score: 0.052
  6. Tishler M, Caspi D, Almog Y, Segal R, Yaron M. Increased incidence of urinary tract infection in patients with rheumatoid arthritis and secondary Sjögren's syndrome. Ann Rheum Dis. 1992 May; 51(5):604-6.
    View in: PubMed
    Score: 0.050
  7. Avrahami E, Wigler I, Bartal G, Sperber F, Yaron M. Ulnar translation of the scaphoid: an early X-ray sign of rheumatoid arthritis. Clin Rheumatol. 1992 Mar; 11(1):101-4.
    View in: PubMed
    Score: 0.049
  8. Tishler M, Moutsopoulos HM, Yaron M. Genetic studies of anti-Ro (SSA) antibodies in families with rheumatoid arthritis. J Rheumatol. 1992 Feb; 19(2):234-6.
    View in: PubMed
    Score: 0.049
  9. Tishler M, Caspi D, Halperin Z, Baratz M, Moshkowitz M, Yaron M. A prospective analysis of liver biopsies in rheumatoid arthritis patients receiving long term methotrexate therapy. Rheumatol Int. 1992; 12(1):39-41.
    View in: PubMed
    Score: 0.049
  10. Elkayam O, Wigler I, Tishler M, Rosenblum I, Caspi D, Segal R, Fishel B, Yaron M. Effect of spa therapy in Tiberias on patients with rheumatoid arthritis and osteoarthritis. J Rheumatol. 1991 Dec; 18(12):1799-803.
    View in: PubMed
    Score: 0.049
  11. Tishler M, Kahn Y, Yaron M. Pure red cell aplasia caused by D-penicillamine treatment of rheumatoid arthritis. Ann Rheum Dis. 1991 Apr; 50(4):255-6.
    View in: PubMed
    Score: 0.046
  12. Tishler M, Caspi D, Graff E, Segal R, Peretz H, Yaron M. Synovial and serum levels of methotrexate during methotrexate therapy of rheumatoid arthritis. Br J Rheumatol. 1989 Oct; 28(5):422-3.
    View in: PubMed
    Score: 0.042
  13. Caspi D, Tishler M, Yaron M. Association between gold induced skin rash and remission in patients with rheumatoid arthritis. Ann Rheum Dis. 1989 Sep; 48(9):730-2.
    View in: PubMed
    Score: 0.042
  14. Segal R, Caspi D, Tishler M, Wigler I, Yaron M. Short term effects of low dose methotrexate on the acute phase reaction in patients with rheumatoid arthritis. J Rheumatol. 1989 Jul; 16(7):914-7.
    View in: PubMed
    Score: 0.041
  15. Fishel B, Tishler M, Caspi D, Yaron M. Fatal aplastic anaemia and liver toxicity caused by D-penicillamine treatment of rheumatoid arthritis. Ann Rheum Dis. 1989 Jul; 48(7):609-10.
    View in: PubMed
    Score: 0.041
  16. Avrahami E, Segal R, Solomon A, Garti A, Horowitz I, Caspi D, Wigler I, Yaron M. Direct coronal high resolution computed tomography of the temporomandibular joints in patients with rheumatoid arthritis. J Rheumatol. 1989 Mar; 16(3):298-301.
    View in: PubMed
    Score: 0.040
  17. Segal R, Caspi D, Tishler M, Fishel B, Yaron M. Accelerated nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis. Arthritis Rheum. 1988 Sep; 31(9):1182-5.
    View in: PubMed
    Score: 0.039
  18. Tishler M, Caspi D, Rosenbach TO, Fishel B, Wigler I, Segal R, Gazit E, Yaron M. Methotrexate in rheumatoid arthritis: a prospective study in Israeli patients with immunogenetic correlations. Ann Rheum Dis. 1988 Aug; 47(8):654-9.
    View in: PubMed
    Score: 0.039
  19. Tishler M, Caspi D, Fishel B, Yaron M. The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients. Arthritis Rheum. 1988 Jul; 31(7):906-8.
    View in: PubMed
    Score: 0.038
  20. Wigler I, Caspi D, Lorber M, Sukenik S, Green L, Fishel B, Tishler M, Segal R, Horovitz J, Yaron M. [Oral gold for rheumatoid arthritis]. Harefuah. 1988 Jun 01; 114(11):529-33.
    View in: PubMed
    Score: 0.038
  21. Tishler M, Caspi D, Gazit E, Yaron M. Association of HLA-B35 with mucocutaneous lesions in Israeli patients with rheumatoid arthritis receiving gold treatment. Ann Rheum Dis. 1988 Mar; 47(3):215-7.
    View in: PubMed
    Score: 0.037
  22. Fishel B, Weiss S, Eventov E, Heldenberg D, Yaron M. Chylous cyst of shoulder joint in a patient with rheumatoid arthritis. Clin Exp Rheumatol. 1988 Jan-Mar; 6(1):79-80.
    View in: PubMed
    Score: 0.037
  23. Tishler M, Caspi D, Yaron M. Classical rheumatoid arthritis associated with nondeforming relapsing polychondritis. J Rheumatol. 1987 Apr; 14(2):367-8.
    View in: PubMed
    Score: 0.035
  24. Rozenbach TO, Caspi D, Tischler M, Yaron M. [Methotrexate for rheumatoid arthritis]. Harefuah. 1987 Jan 01; 112(1):37-8.
    View in: PubMed
    Score: 0.035
  25. Litinsky I, Paran D, Levartovsky D, Wigler I, Kaufman I, Yaron I, Yaron M, Caspi D, Elkayam O. The effects of leflunomide on clinical parameters and serum levels of IL-6, IL-10, MMP-1 and MMP-3 in patients with resistant rheumatoid arthritis. Cytokine. 2006 Jan 21; 33(2):106-10.
    View in: PubMed
    Score: 0.032
  26. Tishler M, Caspi D, Yaron M. C-reactive protein levels in patients with rheumatoid arthritis: the impact of therapy. Clin Rheumatol. 1985 Sep; 4(3):321-4.
    View in: PubMed
    Score: 0.031
  27. Zerbib FR, Goodwin D, Yaron M. [The rehabilitation of the rheumatoid hand]. Harefuah. 1984 Dec 02; 107(11):349-51.
    View in: PubMed
    Score: 0.030
  28. Heldenberg D, Caspi D, Levtov O, Werbin B, Fishel B, Yaron M. Serum lipids and lipoprotein concentrations in women with rheumatoid arthritis. Clin Rheumatol. 1983 Dec; 2(4):387-91.
    View in: PubMed
    Score: 0.028
  29. Elkayam O, Yaron I, Shirazi I, Judovitch R, Caspi D, Yaron M. Active leflunomide metabolite inhibits interleukin 1beta, tumour necrosis factor alpha, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue cultures. Ann Rheum Dis. 2003 May; 62(5):440-3.
    View in: PubMed
    Score: 0.027
  30. Brenner S, Caspi D, Tchetchik R, Krakowski A, Yaron M. [Pemphigus folliaceous following D-penicillamine in rheumatoid arthritis]. Harefuah. 1983 Feb 01; 104(3):94-6.
    View in: PubMed
    Score: 0.026
  31. Elkayam O, Hawkins PN, Lachmann H, Yaron M, Caspi D. Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab. Arthritis Rheum. 2002 Oct; 46(10):2571-3.
    View in: PubMed
    Score: 0.026
  32. Elkayam O, Yaron M, Caspi D. Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis. Ann Rheum Dis. 2002 Jul; 61(7):623-5.
    View in: PubMed
    Score: 0.025
  33. Elkayam O, Paran D, Caspi D, Litinsky I, Yaron M, Charboneau D, Rubins JB. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus. Clin Infect Dis. 2002 Jan 15; 34(2):147-53.
    View in: PubMed
    Score: 0.024
  34. Paran D, Elkayam O, Mayo A, Paran H, Amit M, Yaron M, Caspi D. A pilot study of a long acting somatostatin analogue for the treatment of refractory rheumatoid arthritis. Ann Rheum Dis. 2001 Sep; 60(9):888-91.
    View in: PubMed
    Score: 0.024
  35. Caspi D, Elkayam O, Eisinger M, Vardinon N, Yaron M, Burke M. Clinical significance of low titer anti-nuclear antibodies in early rheumatoid arthritis: implications on the presentation and long-term course of the disease. Rheumatol Int. 2001 Feb; 20(2):43-7.
    View in: PubMed
    Score: 0.023
  36. Elkayam O, Paran D, Flusser G, Wigler I, Yaron M, Caspi D. Insufficiency fractures in rheumatic patients: misdiagnosis and underlying characteristics. Clin Exp Rheumatol. 2000 May-Jun; 18(3):369-74.
    View in: PubMed
    Score: 0.022
  37. Yaron M, Djaldetti M. Platelets in synovial fluid. Arthritis Rheum. 1978 Jun; 21(5):607-8.
    View in: PubMed
    Score: 0.019
  38. Tishler M, Paran D, Yaron M. Allergic disorders in primary Sjögren's syndrome. Scand J Rheumatol. 1998; 27(3):166-9.
    View in: PubMed
    Score: 0.018
  39. Yaron I, Buskila D, Shirazi I, Neumann L, Elkayam O, Paran D, Yaron M. Elevated levels of hyaluronic acid in the sera of women with fibromyalgia. J Rheumatol. 1997 Nov; 24(11):2221-4.
    View in: PubMed
    Score: 0.018
  40. Tishler M, Barak Y, Paran D, Yaron M. Sleep disturbances, fibromyalgia and primary Sjögren's syndrome. Clin Exp Rheumatol. 1997 Jan-Feb; 15(1):71-4.
    View in: PubMed
    Score: 0.017
  41. Elkayam O, Yaron M, Zhukovsky G, Segal R, Caspi D. Toxicity profile of dual methotrexate combinations with gold, hydroxychloroquine, sulphasalazine and minocycline in rheumatoid arthritis patients. Rheumatol Int. 1997; 17(2):49-53.
    View in: PubMed
    Score: 0.017
  42. Yaron M, Yaron I, Smetana O, Eylan E, Herzberg M. Hyaluronic acid produced by human synovial fibroblasts. Effect of polyinosinic-polycytidylic acid (poly I:C) and interferon. Arthritis Rheum. 1976 Nov-Dec; 19(6):1315-20.
    View in: PubMed
    Score: 0.017
  43. Tishler M, Aharon A, Ehrenfeld M, Avni I, Bendet E, Bombardieri S, Yaron M, Shoenfeld Y. Sjogren's syndrome in Israel: primary versus secondary disease. Clin Rheumatol. 1994 Sep; 13(3):438-41.
    View in: PubMed
    Score: 0.015
  44. Meyer FA, Yaron I, Mashiah V, Yaron M. Methotrexate inhibits proliferation but not interleukin 1 stimulated secretory activities of cultured human synovial fibroblasts. J Rheumatol. 1993 Feb; 20(2):238-42.
    View in: PubMed
    Score: 0.013
  45. Elkayam O, Zinger H, Zisman E, Segal R, Yaron M, Brautbar C, Mozes E. Regulatory T cell activity specific to human type II and III collagens in rheumatoid arthritis. J Rheumatol. 1991 Apr; 18(4):516-21.
    View in: PubMed
    Score: 0.012
  46. Segal R, Yaron M, Tartakovsky B. Methotrexate: mechanism of action in rheumatoid arthritis. Semin Arthritis Rheum. 1990 Dec; 20(3):190-200.
    View in: PubMed
    Score: 0.011
  47. Schiff B, Mizrachi Y, Orgad S, Yaron M, Gazit E. Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis. Ann Rheum Dis. 1982 Aug; 41(4):403-4.
    View in: PubMed
    Score: 0.006
  48. Yaron M, Castor CW. Leukocyte-connective tissue cell interaction. I. Stimulation of hyaluronate synthesis by live and dead leukocytes. Arthritis Rheum. 1969 Aug; 12(4):265-73.
    View in: PubMed
    Score: 0.003
  49. Berliner S, Fried M, Caspi D, Weinberger A, Yaron M, Pinkhas J, Aronson M. Evaluation of disease activity in rheumatic patients by leucocyte adhesiveness/aggregation. Ann Rheum Dis. 1988 Jun; 47(6):458-62.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)